Kwon Paul 4
4 · Menlo Therapeutics Inc. · Filed May 4, 2018
Insider Transaction Report
Form 4
Kwon Paul
Chief Scientific Officer
Transactions
- Award
Stock Option
2018-05-03+64,000→ 252,512 totalExercise: $8.49Exp: 2028-05-02→ Common Stock (64,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly.